Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4.
To examine whether the single nucleotide polymorphism at position +4 of the choline acetyltransferase (ChAT) confers a risk for Alzheimer's disease (AD), we determined the ChAT and the Apolipoprotein (APOE) genotypes of the 246 AD patients and 561 non-demented controls. The ChAT AA genotype was found to confer the risk for AD in concert with the APOE epsilon4 by stochastic search variable selection (SSVS) approach. The odds of the ChAT AA for AD were 3.25 (95% CI = 1.17-9.03). The mean ages-at-onset of AD were lower in those carrying the ChAT AA than those carrying the ChAT AG or ChAT GG, regardless to the occurrence of the APOE epsilon4. The ChAT AA is a novel genetic risk factor AD, and the SSVS is a useful approach for analyzing association with multiple candidate genes simultaneously.
Kim
Ki-Woong
KW
Department of Neuropsychiatry, Seoul National University Bundang Hospital, Seongnam, Kyunggi-do, South Korea.
Suh
Young-Ju
YJ
Park
Woong-Yang
WY
Jhoo
Jin-Hyeong
JH
Lee
Dong-Young
DY
Youn
Jong-Chul
JC
Lee
Kwang-Hyuck
KH
Seo
Jeong-Sun
JS
Woo
Jong-Inn
JI
D000368:Aged; D000544:Alzheimer Disease / Q000235:genetics*; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000235:genetics*; D002795:Choline O-Acetyltransferase / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008297:Male; D011110:Polymorphism, Genetic; D012307:Risk Factors; D013269:Stochastic Processes
D053327:Apolipoprotein E4; D001057:Apolipoproteins E; D002795:Choline O-Acetyltransferase